Related Experiment Video
Updated: May 21, 2026
05:16
Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
Published on: August 4, 2021
Recurrent miscarriage and thrombophilia: an update.
Kelly McNamee1, Feroza Dawood, Roy Farquharson
1Liverpool Women's NHS Foundation Trust, Liverpool, UK. kellymcnamee@doctors.org.uk
Current Opinion in Obstetrics & Gynecology
|June 26, 2012
Summary
Recurrent miscarriage is often multifactorial. Antiphospholipid syndrome is a key thrombophilia linked to adverse pregnancy outcomes, but optimal treatment lacks robust evidence, necessitating further research.
Area of Science:
- Reproductive Medicine
- Hematology
Background:
- Recurrent miscarriage (RM) is a significant reproductive challenge.
- Thrombophilia, a predisposition to blood clots, is increasingly studied in RM.
- Optimal management strategies for RM with thrombophilia remain debated.
Purpose of the Study:
- To review and analyze current research on thrombophilia in recurrent miscarriage.
- To explore the latest findings regarding inherited and acquired thrombophilias in RM.
- To identify gaps in knowledge and future research directions.
Main Methods:
- Literature review of recent studies on thrombophilia and RM.
- Appraisal of evidence for diagnostic and therapeutic interventions.
- Synthesis of findings on antiphospholipid syndrome and inherited thrombophilias.
Main Results:
- Antiphospholipid syndrome (APS) is the sole established thrombophilia associated with adverse pregnancy outcomes.
- Evidence for inherited thrombophilia's role in RM is limited to small, heterogeneous studies.
- Current treatment regimens for APS, like aspirin and heparin, lack strong evidence for optimal efficacy.
- Combined inherited and environmental factors are being investigated for high-risk RM individual identification.
Conclusions:
- Recurrent miscarriage etiology is multifactorial, complicating treatment.
- Standardization of laboratory testing is crucial for accurate thrombophilia diagnosis.
- Well-designed, multicenter trials are essential for evidence-based treatment guidelines.
Related Concept Videos
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...